|
Alkermes Plc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 50.95% in the third quarter 2023, year on year to cumulative value of $1,591 million, Alkermes Plc 's revenue per employee grew on a trailing twelve months basis to $ 636,242, this marks a new company high. Within the Healthcare sector Employees of 8 other companies have achieved higher revenue per employee. While Alkermes Plc 's total ranking has deteriorated compared to the previous quarter from 93 to 152. Alkermes Plc has 2,500 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
ALKS Revenue per Employee |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Y / Y Revenue Change |
50.95 % |
123.52 % |
3.25 % |
-6.1 % |
-14.21 % |
Sales per Employee
(TTM) $ |
636,242 |
584,809 |
448,338 |
444,718 |
452,634 |
ALKS's Total
Ranking |
# 152 |
# 93 |
# 1360 |
# 0 |
# 0 |
Seq. Revenue Change |
-38.3 % |
114.68 % |
-5.61 % |
20.73 % |
-8.64 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 636,242 |
$ 391,917 |
$ 236,740 |
(Sep 30 2023) |
|
(Sep. 30, 2014) |
Date modified: 2023-10-26T09:09:48+00:00
Companies with similar Revenue per Employee for 12 months ending Sep 30 2023, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Sep 30 2023 | Number of Employees Sep 30 2023 | Amgen Inc | 1,108,801.65 | $ 26,833.000 Million | 24,200 | Abbvie inc | 1,102,760.00 | $ 55,138.000 Million | 50,000 | Biogen Inc | 1,039,885.54 | $ 9,993.300 Million | 9,610 | Patterson Companies Inc | 935,726.14 | $ 6,550.083 Million | 7,000 | Eli Lilly And Company | 916,357.14 | $ 32,072.500 Million | 35,000 | Adma Biologics Inc | 911,084.29 | $ 233.238 Million | 256 | Merck and Co Inc | 872,264.71 | $ 59,314.000 Million | 68,000 | Pfizer Inc | 867,556.96 | $ 68,537.000 Million | 79,000 | Sarepta Therapeutics Inc | 789,272.86 | $ 1,104.982 Million | 1,400 | Enanta Pharmaceuticals Inc | 707,178.57 | $ 79.204 Million | 112 | Intuitive Surgical Inc | 699,509.85 | $ 6,850.300 Million | 9,793 | Zoetis Inc | 691,818.18 | $ 8,371.000 Million | 12,100 | Agile Therapeutics Inc | 685,321.43 | $ 19.189 Million | 28 | Johnson and Johnson | 672,780.52 | $ 95,333.000 Million | 141,700 | Orthofix Medical Inc | 667,747.00 | $ 667.747 Million | 1,000 | Caredx Inc | 666,230.94 | $ 297.139 Million | 446 | Elanco Animal Health Inc | 666,106.87 | $ 4,363.000 Million | 6,550 | Organon and Co | 661,290.32 | $ 6,150.000 Million | 9,300 | Henry Schein Inc | 587,638.89 | $ 12,693.000 Million | 21,600 | Dexcom Inc | 540,047.62 | $ 3,402.300 Million | 6,300 | Ufp Technologies Inc | 539,314.40 | $ 389.385 Million | 722 | Resmed Inc | 531,961.03 | $ 4,340.802 Million | 8,160 | Illumina Inc | 455,714.29 | $ 4,466.000 Million | 9,800 | Carlisle Companies Incorporated | 451,591.67 | $ 5,419.100 Million | 12,000 | Stryker Corp | 432,282.61 | $ 19,885.000 Million | 46,000 | Viatris Inc | 417,989.19 | $ 15,465.600 Million | 37,000 | Bio techne Corp | 380,803.67 | $ 1,142.411 Million | 3,000 | Agilent Technologies inc | 377,513.81 | $ 6,833.000 Million | 18,100 | Zimmer Biomet Holdings Inc | 373,297.44 | $ 7,279.300 Million | 19,500 | Edwards Lifesciences Corporation | 370,611.46 | $ 5,818.600 Million | 15,700 |
|